Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.

MLA

Batista, Ana Rita, et al. “Response to: Randomized, Assessor-Blinded Trial Comparing Highly Purified Human Menotropin and Recombinant Follicle-Stimulating Hormone in High Responders Undergoing Intracytoplasmic Sperm Injection.” Fertility and Sterility, vol. 121, no. 2, Feb. 2024, p. 358. EBSCOhost, https://doi.org/10.1016/j.fertnstert.2023.09.008.

APA

Batista, A. R., Schwarze, J.-E., & Lispi, M. (2024). Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection. Fertility and Sterility, 121(2), 358. https://doi.org/10.1016/j.fertnstert.2023.09.008

Chicago

Batista, Ana Rita, Juan-Enrique Schwarze, and Monica Lispi. 2024. “Response to: Randomized, Assessor-Blinded Trial Comparing Highly Purified Human Menotropin and Recombinant Follicle-Stimulating Hormone in High Responders Undergoing Intracytoplasmic Sperm Injection.” Fertility and Sterility 121 (2): 358. doi:10.1016/j.fertnstert.2023.09.008.